| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $830.7M | +5.1% |
| R&D Expense | $28.4M | +40.2% |
| SG&A Expense | $168.2M | +17.0% |
| Operating Income | $200.4M | +145.5% |
| Interest Expense | $14.7M | +0.0% |
| Pre-tax Income | $109.8M | +2412.7% |
| Income Tax | $12.3M | +146.7% |
| Net Income | $112.8M | +631.6% |
| EPS (Basic) | $0.95 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $93.5M | +30.1% |
| Accounts Receivable | $98.8M | +7.7% |
| Inventory | $81.3M | -10.8% |
| Current Assets | $292.7M | +8.0% |
| Total Assets | $2.67B | +0.4% |
| Current Liabilities | $169.2M | +28.6% |
| Long-term Debt | $1.76B | +19.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $376.0M | +19.4% |
| Capital Expenditures | $69.9M | -4.9% |
| Investing Cash Flow | -$180.6M | -116.3% |
| Financing Cash Flow | -$170.5M | +47.9% |
| Free Cash Flow | $306.1M | +26.8% |
| +691.7% |
| EPS (Diluted) | $0.94 | +683.3% |
| Total Liabilities |
| $2.09B |
| +18.1% |
| Stockholders' Equity | $576.6M | -35.1% |